The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching

Clinical trial NCT07678645 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07678645
Sponsor: RenJi Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)Atopic Dermatitis (AD)

Start date: 2026-06-01
Primary completion: 2027-11-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.